Gene Therapy for Usher Syndrome
Press Release: ProQR gets FDA orphan status designation for it's investigational drug QRX-411 for Usher Syndrome. Drug shows promise in pre-clinical studies.
Press Release: ProQR gets FDA orphan status designation for it's investigational drug QRX-411 for Usher Syndrome. Drug shows promise in pre-clinical studies.
